Cingulate Inc. Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Cingulate Inc. (CING) had Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount of $181.54 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized · last filed 2026-08-13
- 2026-06-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $181.54K.
- 2026-03-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $195.85K.
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $209.97K.
- 2025-09-30: Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount $124.14K.
| Period end | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount |
|---|---|
| 2026-06-30 | $181.54K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $195.85K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $209.97K 10-K · filed 2026-03-18 |
| 2025-09-30 | $124.14K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |